Study title and authors:
Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system.
Ripollés Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP, Bard JM.
Laboratoire de Biochimie Générale et Appliquée, UFR de Pharmacie, Université de Nantes, 44035 Nantes, France.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/16784973
Laboratoire de Biochimie Générale et Appliquée, UFR de Pharmacie, Université de Nantes, 44035 Nantes, France.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/16784973
This study examined the association of cholesterol levels with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. The study included 21 patients with inflammatory bowel diseases and 28 healthy subjects.
The study found that the patients with inflammatory bowel diseases had significantly lower levels of cholesterol and high-density lipoprotein (HDL) cholesterol than the healthy subjects.
